Percutaneous Intervention in ST-Elevation Myocardial Infarction: Culprit-only or Complete Revascularization?

Area of Science:

• Cardiology
• Interventional Cardiology
• Clinical Trials

Background:

• Multivessel coronary artery disease (CAD) in ST-elevation myocardial infarction (STEMI) presents treatment challenges.
• Current guidelines often do not recommend routine complete revascularization.
• Emerging evidence suggests potential benefits of complete revascularization.

Purpose of the Study:

• To review and objectively present the latest evidence on complete revascularization versus culprit-only revascularization in STEMI with multivessel CAD.
• To inform evidence-based strategies for managing these complex cardiovascular cases.
• To clarify the role of complete revascularization in improving patient outcomes.

Main Methods:

• Systematic review of recent randomized clinical trials.
• Analysis of studies comparing complete revascularization with culprit-lesion-only revascularization.
• Evaluation of cardiovascular outcomes, including mortality and major adverse cardiac events.

Main Results:

• Recent randomized trials indicate a significant reduction in cardiovascular outcomes with complete revascularization.
• Benefits observed include decreased rates of myocardial infarction and repeat revascularization procedures.
• The findings challenge the traditional guideline-based approach for specific patient subgroups.

Conclusions:

• Complete revascularization in STEMI patients with multivessel CAD may offer superior outcomes compared to culprit-lesion-only PCI.
• Further research and guideline updates are warranted to refine treatment strategies.
• Personalized approaches considering patient-specific factors are crucial for optimal management.